Search for Clinical Trial Results

Sponsored By

Angiomatosis - 25 Studies Found

Status Study
Recruiting Study Name: Registry for Vascular Anomalies Associated With Coagulopathy
Condition:
  • Multifocal Lymphangioendotheliomatosis With Thrombocytopenia
  • Cutaneovisceral
  • Procedure: abdominal ultrasound

Recruiting Study Name: A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab
Condition: Von Hippel-Lindau Syndrome
Date: 2016-08-06
Interventions:
  • Drug: Ranibizumab Intravitreal
Recruiting Study Name: Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients
Condition: Von Hippel-Lindau Disease
Date: 2015-04-09
Enrolling by invitation Study Name: Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?
Condition: Von Hippel-Lindaus Disease
Date: 2014-08-01
Completed Study Name: Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease
Condition: Von Hippel-Lindau Disease
Date: 2010-03-18
Interventions: Drug: Sunitinib Sunitinib, 50 mg PO daily, 6 weeks courses with schedule 4/2 (4 weeks of treatment follo
Recruiting Study Name: Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease
Condition: Von Hippel-Lindau Disease
Date: 2003-06-05
Completed Study Name: EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
Condition: Hippel-Lindau Disease
Date: 2003-03-07
Interventions: Drug: EYE001
Active, not recruiting Study Name: Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl System
Condition: Hemangioblastoma (HB) of the Central Nervous System (CNS)
Date: 2014-04-16
Interventions: Other: evaluation of anxiety with psychosocial scales
Enrolling by invitation Study Name: Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)
Condition: Von Hippel-Lindau Disease
Date: 2014-04-05
Interventions: Drug: Vorinostat
Next >>>